LDL-C hypercholesterolemia Cholesterol, LDL Lipoproteins, LDL Hypercholesterolemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Existing data on employees aged 20-40 years old who had been going through an annual medical surveillance at Health Promotion Unit, Maharaj Nakorn Chiang Mai Hospital in the years 2018, 2019, 2020, 2022, and 2023. 2. Prospectively collected data on employees aged 20-40 years old who had been going through an annual medical surveillance at Health Promotion Unit, Maharaj Nakorn Chiang Mai Hospital in the year 2024.
Exclusion criteria
Exclusion criteria: 1. Past ICD-10 medical diagnoses before the check-up day are as follows: essential or familial hypercholesterolemia, hypothyroidism, anorexia nervosa, nephrotic syndrome, current pregnancy. 2. Previous treatment by medication from any time and period in the past lifespan as follows, direct effect of therapeutic agents on LDL-C hypercholesterolemia: statins, ezetimibe, PCSK9 inhibitors, 3. Previous 3 months treatment by medication as follows, indirect effect of common medication on LDL-C: thiazide diuretics, glucocorticoids, amiodarone, cyclosporin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL cholesterol level Not applicable, cross-sectional association Serum LDL cholesterol quantification in mg/dL by Cobas LDL Cholesterol III Gen by the central laboratory, Maharaj Nakorn Chiang Mai Hospital | — |
Secondary
| Measure | Time frame |
|---|---|
| HDL cholesterol Not applicable, cross-sectional association Serum HDL cholesterol quantification in mg/dL by Cobas HDL Cholesterol IV Gen by the central laboratory, Maharaj Nakorn Chiang Mai Hospital,Total cholesterol Not applicable, cross-sectional association Serum cholesterol quantification in mg/dL by Cobas HDL Cholesterol II Gen by the central laboratory, Maharaj Nakorn Chiang Mai Hospital | — |
Countries
Thailand
Contacts
Department of Community Medicine, Chiang Mai University